|
Market Closed -
BME
16:35:08 14/08/2026 BST
|
5-day change | 1st Jan Change | ||
| 57.95 EUR | -0.34% |
|
-0.69% | -8.74% |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A., H1 2026 Earnings Call, Jul 23, 2026 | |
| 07-23 | Laboratorios Farmaceuticos Rovi, S.A. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
Main competitors
| Consensus | Analysts' target price evolution (4 months) | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Average Target P. | Objective/dr gap | Nbr of analysts | ||
|---|---|---|---|---|---|---|---|---|---|
 | 74.36 | +28.31% | 9 | ||||||
| 1,313.08 | +11.26% | 27 | ||||||
| 272.5 | +4.67% | 22 | ||||||
| 276.24 | +10.74% | 29 | ||||||
| 370.31 | +4.28% | 18 | ||||||
| 154.18 | +2.2% | 21 | ||||||
| 211.68 | +36.34% | 22 | ||||||
| 383.66 | -7.6% | 29 | ||||||
| 313.7 | +6.45% | 24 | ||||||
| 157.41 | +13.77% | 27 | ||||||
| 28.61 | +6.78% | 26 | ||||||
| 66.21 | +3.73% | 24 | ||||||
| 563.12 | +11.34% | 25 | ||||||
| 94.28 | +24.84% | 23 | ||||||
| 21.61 | +18.92% | 20 | ||||||
| 9,426.67 | +35.97% | 15 | ||||||
| 6,450.19 | +14.96% | 16 | ||||||
| 56.92 | +19.1% | 18 | ||||||
| 79.69 | +51.44% | 16 | ||||||
| 41.4 | +12.59% | 10 | ||||||
| Average | 1,017.79 | +15.50% | 21 | ||||||
| Weighted average by Cap. | 717.26 | +10.58% | 24 |
- Stock Market
- Stocks
- ROVI Stock
- Sector Laboratorios Farmaceuticos Rovi, S.A.
- Sector consensus
Select your edition
All financial news and data tailored to specific country editions
